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Background: It is well admitted that oxidized LDL (OxLDL) plays a major role in the generation and
progression of atherosclerosis. Since atherosclerosis is often accompanied by osteoporosis, the effects of
OxLDL on phosphate-induced osteoblast mineralization were investigated.
Methods: Calcium deposition, expression of osteoblast markers and inorganic phosphate (Pi) signaling were
determined under OxLDL treatment.
Results: OxLDL, within the range of 10–50 μg protein/ml, inhibited Pi-induced UMR106 rat osteoblast
mineralization. In parallel, the expression of Cbfa1/Runx2 transcription factor was decreased, and the
intracellular level of the osteoblast marker osteopontin (OPN) was reduced. The extracellular level of
another marker, receptor activator of nuclear factor kappa B ligand (RANKL), was also diminished. OxLDL
inhibited Pi signaling via ERK/JNK kinases and AP1/CREB transcription factors. OxLDL triggered the
generation of reactive oxygen species (ROS), either in the absence or presence of Pi. Furthermore, the effects
of OxLDL on Pi-induced mineralization, generation of ROS and extracellular level OPN were reproduced by
the lipid extract of the particle, whereas the antioxidant vitamin E prevented them.
Conclusions: This work demonstrates that OxLDL, by generation of an oxidative stress, inhibits of Pi signaling
and impairs Pi-induced osteoblast differentiation.
General signiﬁcance: This highlights the role of OxLDL in bone remodeling and in degenerative disorders
other than atherosclerosis, especially in osteoporosis.
© 2010 Elsevier B.V. All rights reserved.1. Introduction
Bone mass results from an active remodeling process which
involves an equilibrium between mineralization, mediated by
osteoblasts, and resorption, mediated by osteoclasts. During osteo-
blast differentiation, the expression of osteoblast marker genes such
as alkaline phosphatase and osteocalcin [1], or osteopontin OPN [2,3]
are enhanced. A crosstalk between osteoblasts and osteoclasts exists
in that osteoblast differentiation is accompanied by expression of
RANKL (Receptor Activator of Nuclear Factor kappa B Ligand) [4], a
cytokine involved in osteoclast differentiation. Conversely, inorganicCu2+-oxidized low density
tor of NFkappaB ligand; ERK,
P1, Activator Protein 1; CREB,
oxygen species
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ll rights reserved.phosphate (Pi) released by bone resorption is a signaling molecule in
the events preceeding mineralization of osteoblasts [5]. In MC3T3-E1
mouse osteoblasts, it has been demonstrated that Pi induced OPN
gene expression via ERK and PKC kinases [6]. Other kinases have also
been demonstrated to mediate osteoblast differentiation. In this
regard, PKD activation mediates Bone Morphogenetic Protein 2 BMP2
and Insulin-like Growth Factor 1 IGF1 treatment [7], and p38mediates
diosmetin treatment [8]. JNK is also involved in late-stage osteoblast
differentiation [2].
Concerning the transcription factors, Runx2/Cbfa1/Osf2 plays a
crucial role in bone mineralization [9]. The activity of this factor is
regulated by both gene expression and post-translational regulation.
The expression of Runx2 was demonstrated to be under the control of
PKC [10] and p38 [11]. In addition, the binding activity of Runx2 is
enhanced by phosphorylation via Ras/Raf/ERK1/2 pathway [12].
Besides Runx2, AP1 activation has also been described in BMP2-
induced bone formation [13,14]. In addition, CREB (cyclic AMP
Response Element Binding Protein) phosphorylation and transactiva-
tion has been demonstrated in TNFα-induced mineralization [15].
Direct interactions between Runx2 and other transcription factors
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DNA, were also described [16].
It is well established that oxidized LDL (OxLDL) plays a major role
in the generation and progression of the atherosclerotic plaque (Rev
in [17]). It has been further observed that atherosclerosis is often
accompanied by osteoporosis [18]. We recently reported a role for
OxLDL in bone remodeling in that these particles impair RANKL
signaling and RANKL-induced osteoclast differentiation [19]. In
addition, it was reported that minimally oxidized LDL and lipid
oxidation products, such as oxidized phosphatidyl-choline and
isoprostane8-iso prostaglandin E2, inhibit bone cell differentiation
[20]. This effect of OxLDL has been attributed to generation of an
oxidative stress [21]. However, the molecular mechanism of this
inhibitory effect was not yet described. We previously demonstrated
that OxLDL inhibits insulin signaling and that this effect might be
ascribed to the generation of an oxidative stress [22]. Several reports
mentioned the sensitivity of osteoblasts towards oxidative stress
[23,24], and especially, osteoblasts signaling pathways such as Wnt
pathway might be impaired [25]. In the current study, we demon-
strate that OxLDL prevented Pi-induced differentiation of osteoblasts
and inhibited Pi signaling through ERK/JNK kinases, and AP1/CREB
transcription factors. Furthermore, this phenomenon might be
ascribed to the generation of reactive oxygen species ROS, since the
antioxidant vitamin E prevented it.Fig. 1. OxLDL inhibited Pi-induced mineralization of UMR106 rat osteoblasts. (a) Von Koss
incubated in 48-well plates in DMEM supplemented with 5% foetal calf serum, 4 mM Pi and 1
[26] and calcium deposition by spectrophotometry [27]. 100% calcium: 20–25 μg/well. In c
serum, 4 mM Pi and 50 μg/ml OxLDL protein for 4 days. (b) Means of 3 independent exper2. Materials and methods
2.1. Cell culture
UMR106 rat osteoblasts were purchased from the American Type
Culture Collection. Cells were cultured in DMEM containing 10% foetal
calf serum. For induction of mineralization, cells were shifted to
medium supplemented with 5% foetal calf serum and 4 mM Pi
(NaH2PO4 in 0.2 M stock solution equilibrated to pH 7.4), taking into
account the phosphate content of the medium (1 mM). OxLDL 10–
50 μg protein/ml, and in some experiments 50 μg/ml OxLDL lipid
extract and 50 μM of the antioxidant vitamin E (α-tocopherol from
Sigma) were introduced simultaneously with Pi for 4 days.
Elisa kits for rat OPNwas from IBL, Hambourg, Deutchland, and for rat
RANKL from Biomedica, Vienne, Austria. Determination of intracellular
OPNwas performed on 2 μg protein. Secreted OPNwas determined after
1/100 dilution of culture medium and secreted RANKL was measured
after concentration by a factor 5 using Microcon tubes from Millipore.
For the study of Pi signaling, cellswere preincubated 24 h inmedium
devoid of serum and supplemented with 0.1% bovine albumin in order
to downregulate all signaling pathways. OxLDL were then introduced
for 4 h and 4 mM Pi was added for 45 min. Cellular or nuclear extracts
were then performed for determination of kinase phosphorylation by
western blot, and transcription factor DNA binding activities by Elisa.a staining. (b) Calcium deposition. (c) Cbfa1/Runx2 expression. In a–b, the cells were
0–50 μg OxLDL protein/ml for 8 days. Von Kossa staining was performed as described in
, the cells were incubated in 6 wells-plates in DMEM supplemented with 5% foetal calf
iments±SD. ***pb0.001 by Student's t-test.
Fig. 2. OxLDL inhibited Pi-induced expression of OPN and RANKL. (a) Intracellular OPN.
(b) Secreted RANKL. UMR106 cells were incubated in 12 wells plates in DMEM
supplemented with 5% foetal calf serum, 4 mM Pi and 10–50 μg OxLDL protein/ml for
4 days. RANKL and OPN were determined by Elisa kits. Determination of intracellular
OPNwas performed on 2 μg protein. Secreted OPNwas determined after 1/100 dilution
of culture medium and secreted RANKL was measured after concentration by a factor 5
using Microcon tubes from Millipore. 100% intracellular OPN: 0.5–2.5 ng/μg protein;
secreted RANKL: 35–50 fmol/μg protein. Means of 3 independent experiments±SD.
**pb0.01 and ***pb0.001 by Student's t test.
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Cells were treated in 48 well-plates and calciﬁcation was
visualized using the Von Kossa staining technique in the presence of
AgNO3 for phosphate deposition [26]. Cells were ﬁxed with 95 %
ethanol during 15 min and treated with 5% AgN03 for 30 min in the
dark, with 5% Na2S2O3 for 5 min and then dried at room temperature.
For determination of calcium deposition, cells were treated with
300 μl of 0.6 N HCl for 4 h. Supernatants were then collected and
calcium content was colorimetrically determined by spectrophotom-
etry by the o-cresolphthalein complexone method from Ray Sarkar
[27]. Results are expressed in %, taking as 100% the value obtained
with 4 mM Pi.
2.3. LDL preparation and oxidation
LDL (d 1.024–1.050) was prepared from normal human serum by
sequential ultracentrifugation according to Havel et al. [28], and
dialyzed against 0.005 M Tris, 0.05 M NaCl, 0.02% EDTA pH 7.4 for
conservation. Prior to oxidation, EDTA was removed by dialysis.
Oxidation was performed by incubation at 37 °C of 1 mg LDL protein/
ml Ham F10 with 5.10−6 M CuSO4 for 48 h. The level of LDL oxidation
was checked by determination of thiobarbituric acid reactive
substances (TBARS) according to Yagi [29] and amounted to 38–
42 nmol equivalent malondialdehyde/mg LDL protein. Lipid extrac-
tion of OxLDL was performed according to Bligh and Dyer [30].
2.4. Determination of intracellular OPN, Cbfa1/Runx2 expression and
ERK/JNK phosphorylation by immunoblot analysis
Cells were lysed in 50 mM Tris, 50 mM NaF, 20 mM p-nitrophenyl
phosphate, 1 mMEGTA, 0.05 mMNa-vanadate, 5 mMbenzamidine and
1% TX100 during 15 min at 4 °C and sonicated. After centrifugation at
14,000g for 2 min, the supernatants were taken as cell lysates. Equal
amounts of proteins (40–50 μg) were resolved by SDS-PAGE, trans-
ferred to nitrocellulose membrane, and immunoblotted with speciﬁc
antibodies. Equal loading was checked by neutral red staining. Immu-
noblots were visualized by enhanced chemiluminescence detection kit
from Amersham (Saclay, France). The OPN antibody was from Santa
Cruz (CA, USA), Cbfa1/Runx2 antibody from Calbiochem (CA, USA) and
ERK/JNK antibodies were from Cell Signaling (MA, USA).
2.5. Determination of AP1/CREB DNA binding activities by ELISA
The binding activity assays were performed using the Trans-AM
ELISA-based kits from Active Motif (Carlsbad, CA) according to the
manufacturer's protocol. Nuclear extracts were prepared using Active
Motif kits. Equal amounts of proteins were incubated in 96-well plates
coated with oligonucleotides containing the AP1 or CREB consensus
binding sites. Activated transcription factors bound to the respective
immobilized oligonucleotides were detected using the antibodies
directed against c-jun or CREB, and a secondary antibody conjugated
to horseradish peroxidase. The developing solution was then added
for 10 min at room temperature and OD were determined by a
microplate reader from Molecular Devices. Results are expressed in %
of the OD obtained with non treated cells.
2.6. Determination of reactive oxygen species (ROS) with
chloro-methyl-dichloroﬂuorescein
The increase in ﬂuorescence in living cells in the presence of this
probe allows the quantitation of ROS such as superoxide anion,
hydrogen peroxide and the hydroxyl radical [31].
Cells in 3.5 cm Petri dishes were incubated for 15 minwith 10−5 M
chloro-methyl-2'7'dichloro-ﬂuorescein (Molecular Probes) in PBS,
washed three times with PBS, solubilized in H2O and sonicated. Theﬂuorescencewas determined at 503/529 nm, normalized on a protein
basis and expressed as % of control.
3. Results
3.1. OxLDL inhibited Pi-induced osteoblast mineralization
We ﬁrst studied the effect of OxLDL on mineralization of UMR106
rat osteoblasts, 12 days after 4 mM Pi addition. It was observed that
OxLDL, within the range of 10–50 μg protein/ml, reduced calciﬁcation
Fig. 4. OxLDL impaired Pi signaling via AP1 and CREB. UMR106 cells in 6 wells-plates
were preincubated in DMEM supplemented with 0.1% bovine albumin for down-
regulation of signalling pathways, 10–50 μg OxLDL protein/ml were added for 4 h
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Cbfa1/Runx2 intracellular level (Fig. 1b). OxLDL by itself, in the
absence of Pi, exhibited no effect. Furthermore, native LDL did not
inhibit Pi-induced mineralization (result not shown).
3.2. OxLDL reduced Pi-induced expression of OPN and RANKL
We then investigated the effects of OxLDL on the expression of
speciﬁc osteoblast markers. The data from Fig. 2a show that Pi, as
previously described in mouse osteoblasts [6], enhanced intracellular
OPN by about 4 fold. In addition, in the presence of OxLDL, the Pi-
induced augmentation of OPN was inhibited in a dose-dependent
manner. Concerning RANKL, we were unable to determine its
intracellular level, but extracellular RANKL level could be assessed
after a 5 fold concentration of the culture medium. It was found that
OxLDL also prevented Pi-induced augmentation in extracellular
RANKL in a dose-dependent manner (Fig. 2b).
3.3. OxLDL impaired Pi signaling via ERK/JNK and AP1/CREB
The next experiment was designed to investigate the effects of
OxLDL on Pi signaling. It was found that a 4 h preincubation of
osteoblasts with 10–50 μg/ml OxLDL enhanced ERK and JNK phos-
phorylation (Fig. 3). Pi induced a 2.3- and 1.6-fold increase in ERK and
JNK phosphorylation, respectively, and ﬁnally, OxLDL inhibited Pi-
induced phosphorylation of both kinases.
OxLDL also induced an increase in AP1 binding activity, but had no
effect on CREB (Fig. 4). Pi 4 mM enhanced AP1 and CREB activity by
2.8- and 1.8-fold, respectively and a pre-treatment with OxLDL
prevented this effect, and thus in a dose-dependent manner.
3.4. OxLDL enhanced the oxidative stress initiated by Pi
In the next experiment,wedetermined the intracellular level of ROS
by means of the ﬂuorescent probe dichloro-ﬂuorescein under Pi andFig. 3. OxLDL impaired Pi signaling via ERK (a) and JNK (b). UMR106 cells in 6-well
plates were preincubated in DMEM supplemented with 0.1% bovine albumin for 24 h
for downregulation of signaling pathways, 10–50 μg OxLDL protein/ml were added for
4 h before a further incubation with 4 mM Pi during 45 min. The phosphorylation state
of ERK/JNK was determined by immunoblot analysis. Results are from a typical
experiment. This experiment was performed 3 times with similar results.
before a further incubation with 4 mM Pi during 45 min. AP1/CREB DNA binding
activity was determined with ELISA kits from Active Motif. Results (OD at 450 nm) are
expressed in % of control. Means of 3 independent experiments±SD. ***pb0.001 by
Student's t test.OxLDL treatment. The results from Fig. 5 indicate that a 4-h incu-
bation with 4 mM Pi initiated a slight but signiﬁcant increase (×1.4)
in ROS. Furthermore, OxLDL 10–50 μg/ml increased the generationFig. 5. OxLDL enhanced Pi-induced generation of ROS. UMR106 cells were incubated
in 12-well plates in DMEM supplemented with 0.1% bovine serum albumin for 24 h, 10–
50 μg OxLDL protein/ml were then added for 4 h before a further incubation with 4 mM
Pi for 45 min. Determination of ROS was then performed with the ﬂuorescent probe
chloro-methyl-2'7'dichloroﬂuorescein. Results, normalized on the protein basis, are
expressed in % of control. Means of 3 independent experiments±SD.*pb0.05; **pb0.01
and ***pb0.001 by Student's t test.
Fig. 6. The lipid extract (LE) of OxLDL reproduced whereas Vitamin E prevented the
effects of OxLDL. (a) Reactive oxygen species, (b) Calcium deposition, (c) Intracellular
osteopontin. In a, the cells were preincubated in medium supplemented with 0.1%
albumin and 10 μM vitamin E for 24 h before addition of 50 μg OxLDL protein/ml or its
lipid extract for 4 h. After addition of 4 mM Pi for 45 min, determination of ROS was
performed with the ﬂuorescent probe chloro-methyl-2'7'dichloroﬂuorescein. In b–c,
cells were incubated in medium supplemented with 5% foetal calf serum, 4 mM Pi,
50 μg OxLDL protein/ml or its lipid extract (LE) and 10 μM vitamin E for 8 days (b) or
4 days (c). Means of 3 independent experiments±SD.*pb0.05; **pb0.01 and
***pb0.001 by Student's t test.
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of Pi.
3.5. The lipid extract of OxLDL reproduced whereas vitamin E prevented
the effects of OxLDL
We then investigated the effects of the lipid peroxidation products
included in OxLDL. The data from Fig. 6 indicate that the lipid extract
from OxLDL, like the particle itself, increased Pi-induced generation of
ROS (6A) and simultaneously reduced mineralization (6B) and OPN
level (6C). By contrast, the antioxidant vitamin E partially but
signiﬁcantly reversed these effects of OxLDL and its lipid extract.
4. Discussion
In this study, we ﬁrst demonstrated that OxLDL inhibited Pi-
induced mineralization of UMR rat osteoblasts (Fig. 1a). OxLDL also
prevented Pi-induced expression of Cbfa1/Runx2 transcription factor
(Fig. 1b), and decreased Pi-induced expression of two osteoblastic
markers, OPN and RANKL (Fig. 2). This is in accordancewith the report
from Parhami et al. [20], which described an inhibitory effect of
minimally-oxidized LDL and of oxidized phosphatidyl-choline on
bone cell differentiation. These authors utilized minimally iron-
oxidized LDL at the concentration of 200 μg LDL protein/ml, which
is equivalent, in terms of lipid peroxidation products (TBARS), to the
highest concentration used in our experimental model (50 μg LDL
protein/ml). They further demonstrated that minimally oxidized LDL
inhibits osteogenic differentiation of marrow stromal cells by
directing these cells to undergo adipogenic differentiation by
activation of PPAR alpha [32]. However, these authors only deter-
mined alkaline phosphatase as osteoblast marker, and furthermore,
the effect of OxLDL on osteoblast signaling pathways was not yet
reported.
The current studies demonstrate that in rat osteoblasts, Pi
signaling involves ERK/JNK kinases (Fig. 3), and AP1/CREB transcrip-
tion factors (Fig. 4). Pi transduction signal via ERK in mouse
osteoblasts [6] or via AP1 in BALB/c mouse JB6 epidermal cells [33]
was previously reported. Furthermore, OxLDL alone exhibited the
same stimulatory effect, in accordance with previous reports
concerning ERK [34], JNK [35] and AP1 [36]. However, preincubation
with OxLDL prevented Pi signaling, thus demonstrating a crosstalk
between both activation mechanisms.
It is well admitted that ERK controls AP1 [37] and Cbfa1/Runx2
[38] activities. In addition, the expression of OPN gene was also
demonstrated to be under the control of ERK in smooth muscle cells
[39] or cardiac ﬁbroblasts [40]. It is also of note that ERKmediates OPN
expression in arterial smooth muscle cells by activation of AP1 [41]
and CREB [42]. Concerning the role of JNK in osteoblast differentiation,
it was recently reported that it is essential in the late stage of this
phenomenon [8], and mediates OPN gene expression [42]. Finally, it
has been demonstrated that CREB is one of the transcription factors
involved in RANKL expression [43]. Thus, it is reasonable to assume
that the inhibitory effect of OxLDL on OPN and RANKL gene expression
is related to an impairment of Pi signaling pathways.
Brodeur et al. [44] reported that low concentrations of OxLDL (10–
50 μg/ml) induced proliferation of osteoblasts whereas high concen-
trations (above 150 μg/ml) were cytotoxic. In our experimental
model, generation of ROS and impairment of Pi signaling were
observed after short-term (4 h) incubation with OxLDL, and thus
cannot be ascribed to a cytotoxic effect of these particles. Further-
more, even after 4 days of incubation with Pi and 10–50 μg/ml OxLDL,
the experimental conditions chosen for the study of OPN and RANKL
expression, no cytotoxicity could be detected in our model, as
assessed by the Neutral Red uptake method (data not shown).
It was further demonstrated that Pi induced a signiﬁcant increase
in ROS (Fig. 5), which is in accordance with the report from Shuto et
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extract triggered this effect, whereas the antioxidant vitamin E
prevented it (Fig. 6). In this regard, it can be noted that oxidized
phosphatidylcholine, a lipid component of OxLDL, has been reported
to inhibit spontaneous osteogenic differentiation of marrow stromal
cells [32] and to decrease osteogenic signaling induced by Bone
Morphogenetic Protein 2 and parathyroid hormone in osteoblasts
[46]. Concerning the mechanism whereby OxLDL initiate generation
of ROS, a recent report pointed at the role of CD36 scavenger receptor
and NADPH oxidase [47] in macrophages, whereas the contribution of
lipoxygenase and of the mitochondrial pathways has been described
in vascular smooth muscle cells [48]. Finally, in osteoblasts, Hamel et
al [49] reported the role of NADPH oxidase in OxLDL-induced ROS
generation.
Our studies demonstrate that a moderate generation of ROS,
initiated by a single agent, in our case by OxLDL or Pi, activates
signaling kinases and transcription factors. By contrast, a too high
level of ROS, initiated by OxLDL and 4 h later by Pi, might induce a
negative effect by generation of an “overoxidized” state. In this regard,
it is of note that the oxidative stress caused by hydrogen peroxide also
inhibits Pi-induced mineralization in our experimental system (data
not shown).
It is well known that OxLDL might inhibit hormone and growth
factor signaling pathways, most probably by generation of ROS. In this
regard, it was demonstrated that these particles prevent insulin
signaling in ﬁbroblasts [22], PDGF transduction in vascular cells [50]
or RANKL transduction signal in osteoclasts [19]. It can thus be
supposed that OxLDLmight impair not only Pi signaling but also other
transduction pathways crucial for osteoblast differentiation. It must
be also noted that osteoblasts have the capacity to oxidize LDL [44],
and that OxLDL are thus generated inside bone matrix.
In conclusion, our studies demonstrate that OxLDL inhibits Pi
signaling and Pi-induced mineralization of osteoblasts via generation
of an oxidative stress. OxLDL ﬁnally downregulates the expression of
osteoblast speciﬁc genes such as Cbfa1/Runx2, OPN and RANKL. This
highlights the negative role of OxLDL in bone formation, and points at
its harmful effect in degenerative pathologies such as osteoporosis.
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